Us Bancorp \De\ Deciphera Pharmaceuticals, Inc. Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$13.58 - $17.36 $1,398 - $1,788	-103 Reduced 7.66%	1,241 $19,000
Q4 2023 Feb 09, 2024	SELL	$10.11 - $16.54 $40 - $66	-4 Reduced 0.3%	1,344 $21,000
Q3 2023 Nov 03, 2023	SELL	$12.46 - $15.48 $25,866 - $32,136	-2,076 Reduced 60.63%	1,348 $17,000
Q2 2023 Aug 09, 2023	SELL	$13.28 - $15.96 $11,872 - $14,268	-894 Reduced 20.7%	3,424 $48,000
Q1 2023 May 09, 2023	SELL	$14.26 - $22.1 $2,153 - $3,337	-151 Reduced 3.38%	4,318 $66,000
Q4 2022 Feb 13, 2023	SELL	$14.85 - $19.04 $5,509 - $7,063	-371 Reduced 7.67%	4,469 $73,000
Q3 2022 Oct 27, 2022	BUY	$12.38 - $20.23 $9,755 - $15,941	788 Added 19.45%	4,840 $90,000
Q2 2022 Aug 01, 2022	BUY	$9.11 - $13.98 $18,511 - $28,407	2,032 Added 100.59%	4,052 $53,000
Q1 2022 May 11, 2022	SELL	$6.87 - $11.11 $2,253 - $3,644	-328 Reduced 13.97%	2,020 $18,000
Q4 2021 Feb 11, 2022	BUY	$7.7 - $37.13 $2,825 - $13,626	367 Added 18.53%	2,348 $23,000
Q3 2021 Nov 10, 2021	BUY	$26.46 - $37.15 $9,684 - $13,596	366 Added 22.66%	1,981 $68,000
Q2 2021 Aug 05, 2021	SELL	$32.73 - $47.95 $355,185 - $520,353	-10,852 Reduced 87.05%	1,615 $59,000
Q1 2021 Apr 28, 2021	SELL	$40.39 - $56.73 $3,069 - $4,311	-76 Reduced 0.61%	12,467 $559,000
Q4 2020 Feb 04, 2021	BUY	$51.77 - $66.18 $76,101 - $97,284	1,470 Added 13.28%	12,543 $716,000
Q3 2020 Nov 10, 2020	BUY	$43.8 - $58.16 $355,699 - $472,317	8,121 Added 275.1%	11,073 $568,000
Q2 2020 Aug 07, 2020	BUY	$37.05 - $65.03 $34,789 - $61,063	939 Added 46.65%	2,952 $176,000
Q1 2020 May 13, 2020	BUY	$33.63 - $69.4 $24,549 - $50,662	730 Added 56.9%	2,013 $83,000
Q4 2019 Feb 04, 2020	BUY	$31.7 - $69.93 $19,463 - $42,937	614 Added 91.78%	1,283 $80,000
Q3 2019 Nov 08, 2019	BUY	$19.95 - $38.85 $13,346 - $25,990	669 New	669 $23,000

Others Institutions Holding DCPH

# of Institutions

Shares Held

293K

Call Options Held

500

Put Options Held

View Full List

About Deciphera Pharmaceuticals, Inc.

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

More about DCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account